TY - JOUR T1 - The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 515 LP - 523 DO - 10.3949/ccjm.80a.13030 VL - 80 IS - 8 AU - Bhuvnesh Aggarwal AU - Sachin S. Goel AU - Joseph F. Sabik AU - Mehdi H. Shishehbor Y1 - 2013/08/01 UR - http://www.ccjm.org/content/80/8/515.abstract N2 - The Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial (N Engl J Med 2012; 367:2375–2384) was designed to resolve the long-standing debate over the optimal revascularization strategy in patients with diabetes mellitus and multivessel coronary artery disease. At a median follow-up of 3.8 years, the incidence of the primary outcome (a composite of death, myocardial infarction, and stroke) was significantly lower with bypass surgery than with percutaneous intervention. ER -